Related Experiment Video
Updated: Aug 23, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy
Ylenia D'Agostino1,2, Domenico Palumbo1,3, Maria Rosaria Rusciano1
1Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, 84081 Baronissi, Italy.
Insights
Dilated cardiomyopathy (DCM) is a complex heart condition. Whole-exome sequencing identified numerous genetic variants, including potential new players in DCM, aiding genetic diagnosis and prognosis.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure, particularly in young adults.
- Its complex etiology involves genetic and environmental factors, leading to varied clinical presentations.
- Early genetic diagnosis is crucial for intervention, prognosis, and understanding disease mechanisms.
Purpose of the Study:
- To identify causative gene mutations in patients with dilated cardiomyopathy using whole-exome sequencing.
- To explore novel genetic variants associated with DCM and understand their functional implications.
- To enhance diagnostic capabilities and predictive insights for DCM.
Main Methods:
- Whole-exome sequencing (WES) was performed on 15 patients diagnosed with DCM.
- Pathogenic, likely pathogenic, and variants of uncertain clinical significance were identified.
- Gene ontology enrichment analysis was conducted to explore biological functions of affected genes.
Main Results:
- Seventy pathogenic or likely pathogenic variants and 1240 variants of uncertain clinical significance were detected.
- Enrichment analysis highlighted genes involved in extracellular matrix organization, solute transport, and vitamin B12 metabolism.
- Several variants in genes with known or potential roles in cardiac function were identified.
Conclusions:
- Whole-exome sequencing is a powerful tool for identifying genetic variants in dilated cardiomyopathy.
- The study identified potential novel genetic contributors to DCM, impacting extracellular matrix, transport, and metabolism.
- Findings advance the understanding of DCM's genetic landscape, potentially improving diagnosis and therapeutic strategies.
Abstract:
Dilated cardiomyopathy (DCM) is a complex disease affecting young adults. It is a pathological condition impairing myocardium activity that leads to heart failure and, in the most severe cases, transplantation, which is currently the only possible therapy for the disease. DCM can be attributed to many genetic determinants interacting with environmental factors, resulting in a highly variable phenotype. Due to this complexity, the early identification of causative gene mutations is an important goal to provide a genetic diagnosis, implement pre-symptomatic interventions, and predict prognosis. The advent of next-generation sequencing (NGS) has opened a new path for mutation screening, and exome sequencing provides a promising approach for identifying causal variants in known genes and novel disease-associated candidates. We analyzed the whole-exome sequencing (WES) of 15 patients affected by DCM without overloading (hypertension, valvular, or congenital heart disease) or chronic ischemic conditions. We identified 70 pathogenic or likely pathogenic variants and 1240 variants of uncertain clinical significance. Gene ontology enrichment analysis was performed to assess the potential connections between affected genes and biological or molecular function, identifying genes directly related to extracellular matrix organization, transcellular movement through the solute carrier and ATP-binding cassette transporter, and vitamin B12 metabolism. We found variants in genes implicated to a different extent in cardiac function that may represent new players in the complex genetic scenario of DCM.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...

